COVID Risk | Literature database and meta-analysis page 17

Last update : 2021-08-05 08:37:15 (GMT+2) | 276 factors investigated | 1766 estimates included | 219 articles processed | QC progress: 50%

Receive updates on COVID-19 risk factors

Associated factors

Risk category:

Risk name:

Outcomes

Outcome description:

Filters

Adjusted analysis:

Author:

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.

Green: significant protective factor
Red: significant risk factor
^§ adjusted estimate (see article details)
^† estimated using data reported in the article

Outcome	Risk category	Risk [exposed vs. unexposed]	Risk estimate (95% CI)	Author [URL]	View	QC
SARS COV-2 infection	Other	Symptoms of infected persons in households [No fever vs. Fever]	Odds ratio: 0.610 (0.300-1.240) ^§	Li
SARS COV-2 infection	Other	Gender of in the infected person in households [Female vs. Male]	Odds ratio: 0.790 (0.420-1.470) ^§	Li
SARS COV-2 infection	Other	Relationship with infected persons [Spouse vs. No spouse]	Odds ratio: 2.270 (1.220-4.220) ^§	Li
SARS COV-2 infection	Patient characteristics	Age [<18 years vs. >=18 years]	Odds ratio: 0.180 (0.060-0.540) ^§	Li
SARS COV-2 infection	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 0.920 (0.510-1.640) ^§	Li
COVID-19 (death)	Comorbidities	Inflammatory bowel disease [Present vs. Not present]	Odds ratio: 0.950 (0.840-1.060)	Taxonera
SARS COV-2 infection	Comorbidities	Inflammatory bowel disease [Present vs. Not present]	Odds ratio: 0.740 (0.700-0.770)	Taxonera
COVID-19 (severe/critical)	Status	Time from symptom onset to hospital admission [>=4 days vs. <4 days]	Risk ratio: 0.350 (0.190-0.670) ^§	Yang
COVID-19 (severe/critical)	Laboratory Findings	eGFR [Abnormal vs. Normal]	Risk ratio: 1.630 (0.670-4.000) ^§	Yang
COVID-19 (severe/critical)	Laboratory Findings	Homocysteine [Abnormal vs. Normal]	Risk ratio: 3.170 (1.010-9.960) ^§	Yang
COVID-19 (severe/critical)	Laboratory Findings	Serum cystatin C [Abnormal vs. Normal]	Risk ratio: 0.790 (0.280-2.200) ^§	Yang
COVID-19 (severe/critical)	Laboratory Findings	Monocyte–Lymphocyte ratio [1 unit increase vs. Not applicable]	Risk ratio: 7.690 (1.670-35.550) ^§	Yang
COVID-19 (severe/critical)	Treatment	Treatment for COVID-19 [Treated with Thymosin therapy vs. Not received]	Risk ratio: 2.320 (0.940-5.730) ^§	Yang
COVID-19 (severe/critical)	Treatment	Treatment for COVID-19 [Treated with Gamma globulin therapy vs. Not received]	Risk ratio: 1.080 (0.380-3.080) ^§	Yang
COVID-19 (severe/critical)	Patient characteristics	Age [>=60 years vs. <60 years]	Risk ratio: 2.280 (1.120-4.340) ^§	Yang
COVID-19 (severe/fatal)	Findings	Radiological finding on admission [1% increase of pulmonary lesion ratio vs. Not applicable]	Odds ratio: 1.100 (1.070-1.150)	Wei
COVID-19 (severe/fatal)	Laboratory Findings	Hs-TnI [Abnormal at admission vs. Normal]	Odds ratio: 6.630 (2.240-19.650)	Wei
COVID-19 (severe/fatal)	Laboratory Findings	Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [Abnormal at admission vs. Normal]	Odds ratio: 2.800 (1.740-4.520)	Wei
COVID-19 (severe/fatal)	Laboratory Findings	eGFR [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 0.970 (0.950-0.990)	Wei
COVID-19 (severe/fatal)	Laboratory Findings	CRP [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 1.020 (1.010-1.040)	Wei
COVID-19 (severe/fatal)	Laboratory Findings	WBC [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 1.070 (0.930-1.240)	Wei
COVID-19 (severe/fatal)	Treatment	Concomitant medication [Treated with calcium channel blocker vs. Not received]	Odds ratio: 4.280 (1.190-15.360)	Wei
COVID-19 (severe/fatal)	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 2.820 (0.450-17.720)	Wei
COVID-19 (severe/fatal)	Patient characteristics	Smoking [Present vs. Not present]	Odds ratio: 3.280 (0.740-14.610)	Wei
COVID-19 (severe/fatal)	Comorbidities	Cerebrovascular disease [Present vs. Not present]	Odds ratio: 10.160 (1.140-90.600)	Wei
COVID-19 (severe/fatal)	Comorbidities	Diabetes [Present vs. Not present]	Odds ratio: 2.760 (0.880-8.690)	Wei
COVID-19 (severe/fatal)	Comorbidities	Hypertension [Present vs. Not present]	Odds ratio: 5.360 (1.910-15.040)	Wei
COVID-19 (severe/fatal)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 1.470 (0.300-1.540)	Wei
COVID-19 (severe/fatal)	Patient characteristics	Age [1 unit increase vs. Not applicable]	Odds ratio: 1.070 (1.040-1.100)	Wei
COVID-19 (severe/critical)	Complications	Coagulopathy [Present vs. Not present]	Hazard ratio: 4.100 (1.900-9.100) ^§	Klok
COVID-19 (severe/critical)	Patient characteristics	Age [1 year increase vs. Not applicable]	Hazard ratio: 1.050 (1.004-1.100) ^§	Klok
COVID-19 (severe/critical)	Treatment	Treatment for COVID-19 [Treated with corticosteroid vs. Not received]	Risk ratio: 2.360 (1.310-4.280) ^§	Yang
COVID-19 (death)	Laboratory Findings	D-dimer [Abnormal vs. Normal]	Hazard ratio: 3.070 (0.590-15.980) ^§	Xie
COVID-19 (death)	Laboratory Findings	CRP [Abnormal vs. Normal]	Hazard ratio: 17.020 (2.250-128.590) ^§	Xie
COVID-19 (death)	Laboratory Findings	Platelet count [Abnormal vs. Normal]	Hazard ratio: 2.230 (1.010-4.920) ^§	Xie
COVID-19 (death)	Laboratory Findings	Lymphocyte count [Abnormal vs. Normal]	Hazard ratio: 1.100 (0.500-2.410) ^§	Xie
COVID-19 (death)	Laboratory Findings	Neutrophils [Abnormal vs. Normal]	Hazard ratio: 4.290 (1.740-10.580) ^§	Xie
COVID-19 (death)	Laboratory Findings	WBC [Abnormal vs. Normal]	Hazard ratio: 2.560 (1.170-5.630) ^§	Xie
COVID-19 (death)	Vital Signs	Oxygen saturation [Abnormal vs. Normal]	Hazard ratio: 47.410 (6.290-357.480) ^§	Xie
COVID-19 (death)	Vital Signs	Oxygen saturation [1 unit increase vs. Not applicable]	Hazard ratio: 0.930 (0.910-0.950) ^§	Xie
COVID-19 (death)	Comorbidities	Any comorbidity [Present vs. Not present]	Hazard ratio: 2.650 (1.070-6.550) ^§	Xie
COVID-19 (death)	Comorbidities	Hypertension [Present vs. Not present]	Hazard ratio: 1.190 (0.610-2.330) ^§	Xie
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with aspirin vs. Not received]	Odds ratio: 0.510 (0.120-2.130) ^§	Yan
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with Statins vs. Not received]	Odds ratio: 0.980 (0.320-2.990) ^§	Yan
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with insulin vs. Not received]	Odds ratio: 2.960 (0.810-10.770) ^§	Yan
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with DPP.4 inhibitor vs. Not received]	Odds ratio: 0.200 (0.020-1.980) ^§	Yan
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with thiazolidinediones vs. Not present]	Odds ratio: 4.520 (0.340-59.540) ^§	Yan
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with insulin secretagogues vs. Not received]	Odds ratio: 1.140 (0.270-4.700) ^§	Yan
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with biguanides vs. Not received]	Odds ratio: 0.720 (0.230-2.250) ^§	Yan
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with biguanides vs. Not received]	Odds ratio: 0.720 (0.230-2.250) ^§	Yan

If a relevant publication escaped our attention, please contact us.